These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33743630)

  • 1. Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.
    Zou X; Xu ZQ; Wang HR; Wang BX; He JF; Wang JZ
    BMC Public Health; 2021 Mar; 21(1):551. PubMed ID: 33743630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological Characteristics of COVID-19 and Effective Public Health Interventions in Shenzhen, China.
    Li G; Lin J; Xu D
    Front Public Health; 2022; 10():923175. PubMed ID: 35844887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To halt the spread of imported coronavirus disease 2019 cases in China: Action and challenges.
    Fu J; Jiang C; Wang J; Li Y; Ying H
    Travel Med Infect Dis; 2021; 39():101913. PubMed ID: 33171285
    [No Abstract]   [Full Text] [Related]  

  • 4. Notes from the Field: Effectiveness of Prevention and Control Measures for Imported COVID-19 in Guangming District of Shenzhen.
    Chen X; Wang T; Zhao Y; Wu Y; Qie R; Han M; Huang S; Du H; Yao W; Hu D
    Eval Health Prof; 2021 Mar; 44(1):93-97. PubMed ID: 33203226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Countries of origin of imported COVID-19 cases into China and measures to prevent onward transmission.
    Zhang ZB; Li L; Qin PZ; Li K; Huang Y; Luo L; Ou CQ
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 32841347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19.
    Zou H; Shu Y; Feng T
    Infect Dis Poverty; 2020 Jul; 9(1):89. PubMed ID: 32650840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soaring Asymptomatic Infected Individuals Bring About Barriers and Difficulties for Interruption of COVID-19 Prevalence in China.
    Chen M; Ai L; Huang D; Chen J; Feng T; Mei S; Huang Y; Peng B; Zhang S; Zhang R; Zhou X
    Vector Borne Zoonotic Dis; 2021 Oct; 21(10):777-784. PubMed ID: 34375121
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiological features of domestic and imported cases with COVID-19 between January 2020 and March 2021 in Taiwan.
    Wu CH; Chou YC; Lin FH; Hsieh CJ; Wu DC; Peng CK; Yu CP
    Medicine (Baltimore); 2021 Oct; 100(39):e27360. PubMed ID: 34596146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study.
    Russell TW; Wu JT; Clifford S; Edmunds WJ; Kucharski AJ; Jit M;
    Lancet Public Health; 2021 Jan; 6(1):e12-e20. PubMed ID: 33301722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological characteristics and measures of prevention and control of imported COVID-19 cases in early phase in Shanghai].
    Fang QW; Gong XH; Xiao WJ; Jin BH; Yu X; Cui P; Han RB; Kong DC; Wu HY; Pan H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2034-2039. PubMed ID: 33378813
    [No Abstract]   [Full Text] [Related]  

  • 11. Compare the epidemiological and clinical features of imported and local COVID-19 cases in Hainan, China.
    Wu B; Lei ZY; Wu KL; He JR; Cao HJ; Fu J; Chen F; Chen Y; Chen B; Zhou XL; Huang T; Wu T; Du YG; Chen SX; Xiao FR; Gao ZL; He J; Lin F; Lin BL
    Infect Dis Poverty; 2020 Oct; 9(1):143. PubMed ID: 33076968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission dynamics and successful control measures of SARS-CoV-2 in the mega-size city of Guangzhou, China.
    Zhao H; Zhang Z; Lun W; Chen Z; Lu X; Li J; Qiu F; Li S; Mao C; Lu Y; Chen J; He Q; Lu J; Yang Z
    Medicine (Baltimore); 2021 Dec; 100(48):e27846. PubMed ID: 35049185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of coronavirus disease 2019 (COVID-19): experiences from imported malaria control in China].
    Liu YB; Cao J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Mar; 32(2):113-118. PubMed ID: 32458598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustainable border control policy in the COVID-19 pandemic: A math modeling study.
    Zhu Z; Weber E; Strohsal T; Serhan D
    Travel Med Infect Dis; 2021; 41():102044. PubMed ID: 33838318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological characteristics of COVID-19 in Shenzhen, China: comparison between imported and local cases.
    Li Z; Wang J; Huang J; Lu J
    J Infect Dev Ctries; 2020 Aug; 14(8):853-860. PubMed ID: 32903229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The analysis of the characteristics of imported COVID-19 cases from January to April in 2020: a cross-sectional study.
    Huang J; Chen SW; Han N; Liu ZM; Xiao WW; Jiang BQ; Han MX
    Ann Transl Med; 2022 Oct; 10(20):1131. PubMed ID: 36388784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020.
    Lam HY; Lam TS; Wong CH; Lam WH; Leung CME; Au KWA; Lam CKY; Lau TWW; Chan YWD; Wong KH; Chuang SK
    Int J Infect Dis; 2020 Sep; 98():51-58. PubMed ID: 32579906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Time distribution of positive nucleic acid detection in imported cases infected with SARS-CoV-2 in China].
    Li ZL; Li Y; Chen QL; Jiang XL; Yang XK; Qin Y; Peng ZB; Yu JX; Li ZJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Feb; 43(2):183-188. PubMed ID: 35184482
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.
    Böhmer MM; Buchholz U; Corman VM; Hoch M; Katz K; Marosevic DV; Böhm S; Woudenberg T; Ackermann N; Konrad R; Eberle U; Treis B; Dangel A; Bengs K; Fingerle V; Berger A; Hörmansdorfer S; Ippisch S; Wicklein B; Grahl A; Pörtner K; Muller N; Zeitlmann N; Boender TS; Cai W; Reich A; An der Heiden M; Rexroth U; Hamouda O; Schneider J; Veith T; Mühlemann B; Wölfel R; Antwerpen M; Walter M; Protzer U; Liebl B; Haas W; Sing A; Drosten C; Zapf A
    Lancet Infect Dis; 2020 Aug; 20(8):920-928. PubMed ID: 32422201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 control strategies in Taizhou city, China.
    Lin H; Guo C; Hu Y; Liang H; Shen W; Mao W; He N
    Bull World Health Organ; 2020 Sep; 98(9):632-637. PubMed ID: 33012863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.